Skip to main content

Table 2 Distribution of pediatric patients: sex, age, Phe levels

From: Quality of Life (QoL) assessment in a cohort of patients with Phenylketonuria

Pediatric patients
Pediatric patients on BH4treatment* Age Sex Phe valuesaon the day of assessment Mean Phe valuesaover the course of the previous 12 months
I 6 F 313 292
II 10 M 416 361
III 8 F 358 350
IV 8 F 326 250
V 10 M 373 254
VI 10 F 664 553
VII 7 M 268 261
VIII 16 F 189 256
IX 6 M 254 335
X 10 F 222 224
XI 6 M 142 166
XII 11 F 240 251
XIII 16 F 309 364
XIV 16 M 251 268
XV 7 F 259 271
Pediatric patients on dietary treatment Age Sex Phe values a on the day of assessment Mean Phe values a over the course of the previous 12 months
XVI 15 M 471 318
XVII 8 M 473 343
XVIII 15 F 611 394
IXX 15 M 262 386
XX 8 M 273 291
XXI 10 F 396 320
XXII 13 F 128 476
XXIII 13 F 239 216
XXIV 9 F 288 321
XXV 16 F 563 678
XXVI 12 M 254 206
  1. *10 mg/Kg/day for each patient.
  2. aExpressed in ╬╝mol/L.